Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,410.80
(
-2.36%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
6.18%
)
Bitcoin
66,340.01
(
0.00%
)
News Focus
News Focus
Post# of 257299
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ronpopeil

Send PM Follow Ignore
Followers 123
Posts 8886
Boards Moderated 0
Alias Born 10/05/2004

ronpopeil

Re: None

Tuesday, 08/21/2018 12:38:26 PM

Tuesday, August 21, 2018 12:38:26 PM

Post# of 257299
EMIS has a 2.5% royalty on NVO's oral semaglutide treatment which an analyst predicts could have $7 billion/year in revenue. That would be $140+ million in royalty income to tiny EMIS each year plus they could make other deals as well

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today